Open Access UCL Research: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care https://t.co/jCwvrukCY2
RT @CochraneJapan: がん患者および緩和ケアを受けている患者におけるオピオイド使用に伴う腸機能障害に対するμオピオイド拮抗薬 https://t.co/lpCNiztkxv
がん患者および緩和ケアを受けている患者におけるオピオイド使用に伴う腸機能障害に対するμオピオイド拮抗薬 https://t.co/cf31hgqGi8
RT @CochraneJapan: がん患者および緩和ケアを受けている患者におけるオピオイド使用に伴う腸機能障害に対するμオピオイド拮抗薬 https://t.co/lpCNiztkxv
がん患者および緩和ケアを受けている患者におけるオピオイド使用に伴う腸機能障害に対するμオピオイド拮抗薬 https://t.co/lpCNiztkxv
RT @CochranePaPaS: Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people re…
RT @CochraneIberoam: ¿Son efectivos y seguros los antagonistas de los receptores opioides mu para la disfunción intestinal por los opiáceos…
¿Son efectivos y seguros los antagonistas de los receptores opioides mu para la disfunción intestinal por los opiáceos en personas con cáncer y que reciben cuidados paliativos? Mira lo que concluye esta actualización de una revisión @CochranePaPaS: https
Mu-opioid antagonists (#PAMORA) for bowel dysfunction due to opioids in people with cancer and people receiving palliative care @CochraneLibrary https://t.co/nxp0RkjNHH
Mu‐opioid antagonists for opioid‐induced bowel dysfunction in people with #cancer and people receiving #palliative care https://t.co/lv4TlpGmFx
Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care, now includes 10 studies of 1343 participants https://t.co/mBrmhatvYR https://t.co/tDNBzYhWyT
RT @CochranePaPaS: Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people re…
RT @CochranePaPaS: Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people re…
RT @CochranePaPaS: Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people re…
Updated #Cochrane review: Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care, now includes 10 studies of 1343 participants https://t.co/mBrmhasY9j https://t.co/tUuzqYFNGI
Mu-opioid antagonists for opioid-induced bowel dysfunction in people with cancer and people receiving palliative care https://t.co/y8FlnYfqiV